With its enhanced potency, ProAct 360™ offers improved returns on investment and its value proposition goes beyond the product itself. It includes a unique set of value-adding end-to-end digital services, ranging from raw material analysis to a sustainability calculator, that enable deeper insights and more informed decision-making.
Robert Vergo, Account Director, Global Strategic Accounts at Novozymes, comments: “ProAct 360™ is the latest of many ground-breaking innovations from the DSM | Novozymes Feed Enzymes Alliance. Selected via a rigorous screening process involving more than 500 protease candidates, it is a novel and robust protease product tailored to the needs of today’s feed industry. ProAct 360™ has been perfected for progress, reflecting a complete perspective on our customers’ commercial sustainability plans and targets. With the launch of this second-generation protease, we are inviting our customers to join us on the journey toward a genuinely sustainable animal production industry.”
Christie Chavis, Vice President at DSM Animal Nutrition and Health, observes: “ProAct 360™ is our latest breakthrough technology in sustainability-driven innovation. Improving sustainability while reducing feed costs and supporting animal welfare is the key requirement for the animal protein industry today. The launch of ProAct 360™ is an important proof point of our strategic initiative We Make it Possible, which is designed to deliver solutions that enable the transition to fully sustainable animal protein production worldwide.”
The DSM | Novozymes Alliance pioneered feed protease technology 10 years ago with the launch of its first-generation ProAct, which became the market standard for improving amino acid digestibility in animal feed. The need for protease-based solutions is greater than ever today, with animal protein producers facing a volatile market characterized by high protein meal prices and a slow recovery from the effects of the COVID-19 pandemic.
With the launch of ProAct 360™, the DSM | Novozymes Alliance intends to make protease technology broadly available to poultry customers, to support the development of a more sustainable global animal production industry, once more delivering on its We Make it Possible promise.
ProAct 360™ will initially be launched in the markets of Latin America, with a roll-out to the other regions of the world to follow in the medium term. Future swine applications are being studied.
